A high-field operation of p+–n structure blue-ultraviolet photodetectors has been studied using ZnSe-based II–VI wide-band-gap compound semiconductors grown by molecular-beam epitaxy (MBE). With an improved crystal quality on macrodefects (dislocations and stacking faults) during an initial MBE growth as well as an optimized device structure including a complete superlattice ohmic-contact layer, a stable high electric-field operation up to 8×105 V/cm is established. It is demonstrated that the p+–n ZnSe photodiodes have shown a stable avalanche-photodiode operation with a large avalanche gain of G=60 in the blue-ultraviolet region at room temperature.
Subject classification: 68.55. Ln; 72.40.+w; 81.15.Hi; 85.60.Dw; 85.60.Gz; S8.12; S8.15 II-VI ZnSe (binary) and ZnSSe (ternary) widegap compound semiconductor based photovoltaic devices (p-i-n and avalanche photodiodes (APDs)) are developed for the blue-violet (460-400 nm) optical wavelength region by molecular beam epitaxial (MBE) growth. The ternary compound ZnSSe p-i-n structure photodiodes, grown with complete lattice matched condition on GaAs substrates, exhibit high external quantum efficiencies of 80-70% in the blue-violet optical region with extremely low dark currents (~pA/mm 2 ), These diodes reveal stable and long-lived operation at 300 K. Also presented is ZnSe and ZnSSe based blue-violet APD devices, fabricated by precise defect control and process techniques. This new device has revealed large signal gain (G) of G = 50 for ZnSe, and G = 60 for the ZnSSe APD device under high electric field strength of (0.8-1.1) Â 10 6 V/cm. Important device parameters, ionization coefficients of photo-injected electrons and holes, and device stability are also discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.